Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine efficacy of a Mycobacterium tuberculosis Beijing‐specific proline‐glutamic acid (PE) antigen against highly virulent outbreak isolates
Kee Woong Kwon, Hong‐Hee Choi, Seung Jung Han, et al.
The FASEB Journal (2019) Vol. 33, Iss. 5, pp. 6483-6496
Closed Access | Times Cited: 9

Showing 9 citing articles:

Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx
Tae Gun Kang, Kee Woong Kwon, Kyung Soo Kim, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion
Hongmin Kim, Sung Jae Shin
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 25
Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model
Kee Woong Kwon, Ara Lee, Sasha E. Larsen, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine
Han‐Gyu Choi, Kee Woong Kwon, Seunga Choi, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 300-300
Open Access | Times Cited: 31
Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains
Kee Woong Kwon, Han‐Gyu Choi, Hong‐Hee Choi, et al.
Vaccine (2024) Vol. 42, Iss. 8, pp. 1941-1952
Closed Access | Times Cited: 3
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice
Kee Woong Kwon, Han‐Gyu Choi, Kwang Sung Kim, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Preclinical Progress of Subunit and Live Attenuated Mycobacterium tuberculosis Vaccines: A Review following the First in Human Efficacy Trial
Jacqueline Watt, Jun Liu
Pharmaceutics (2020) Vol. 12, Iss. 9, pp. 848-848
Open Access | Times Cited: 14
Fms-Like Tyrosine Kinase 3-Independent Dendritic Cells Are Major Mediators of Th2 Immune Responses in Allergen-Induced Asthmatic Mice
Sang Chul Park, Dahee Shim, Hongmin Kim, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9508-9508
Open Access | Times Cited: 9
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection
Lee‐Han Kim, Soon Myung Kang, Jake Whang, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 2
Page 1

Scroll to top